JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

Search

Treace Medical Concepts Inc

Fechado

5.59

Visão Geral

Variação de preço das ações

24h

Atual

Mín

5.45

Máximo

5.6

Indicadores-chave

By Trading Economics

Rendimento

-15M

-16M

Vendas

-16M

53M

Margem de lucro

-30.287

Funcionários

477

EBITDA

-15M

-12M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+93.82% upside

Dividendos

By Dow Jones

Próximos Ganhos

7 de ago. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-91M

362M

Abertura anterior

5.59

Fecho anterior

5.59

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

Treace Medical Concepts Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

5 de ago. de 2025, 23:11 UTC

Ganhos

Australia's REA Hikes Dividend as Annual Profit Rises 23% -- Update

5 de ago. de 2025, 22:45 UTC

Ganhos

Australia's REA Hikes Dividend as Annual Profit Rises 23%

5 de ago. de 2025, 22:39 UTC

Ganhos

Great-West Lifeco Logs Lower 2Q Profit

5 de ago. de 2025, 21:32 UTC

Ganhos

Coupang Posts Higher 2Q Sales Due to Customer Growth

5 de ago. de 2025, 23:48 UTC

Conversa de Mercado

Nikkei May Decline Amid U.S. Economic Uncertainty -- Market Talk

5 de ago. de 2025, 23:40 UTC

Conversa de Mercado

Gold Edges Higher, Supported by Fed Rate-Cut Hopes -- Market Talk

5 de ago. de 2025, 23:19 UTC

Conversa de Mercado

Lindian Deal With Iluka Demonstrates Kangankunde Project Appeal -- Market Talk

5 de ago. de 2025, 23:03 UTC

Conversa de Mercado
Ganhos

Advanced Micro Devices' Data-Center Story Seen as Promising -- Market Talk

5 de ago. de 2025, 22:22 UTC

Ganhos

REA: Expectation of More Interest-Rate Cuts Likely to Support Buyer Demand>REA.AU

5 de ago. de 2025, 22:21 UTC

Ganhos

REA Expects FY26 Listing Volumes Broadly Flat on FY25>REA.AU

5 de ago. de 2025, 22:20 UTC

Ganhos

REA Expects September-Quarter Listings to Be Down on Year>REA.AU

5 de ago. de 2025, 22:18 UTC

Ganhos

REA July 2025 New Residential Listings Down 8% on Year>REA.AU

5 de ago. de 2025, 22:17 UTC

Ganhos

REA FY25 Australian Residential Listings Up 1% on Year>REA.AU

5 de ago. de 2025, 22:17 UTC

Ganhos

REA FY25 India Revenue A$129M Vs. A$103M>REA.AU

5 de ago. de 2025, 22:16 UTC

Ganhos

REA FY25 Core Australia Revenue A$1.54B Vs. A$1.35B>REA.AU

5 de ago. de 2025, 22:16 UTC

Ganhos

REA FY25 Core Operations Net Profit A$564.4M Vs. A$460.5M>REA.AU

5 de ago. de 2025, 22:15 UTC

Ganhos

REA Group FY25 Ebitda A$969.2M Vs. A$824.8M>REA.AU

5 de ago. de 2025, 22:13 UTC

Ganhos

REA Group Raises Dividend to A$1.38 Vs. A$1.02 >REA.AU

5 de ago. de 2025, 22:13 UTC

Ganhos

REA Group FY25 Rev A$1.67B Vs. A$1.45B >REA.AU

5 de ago. de 2025, 22:12 UTC

Ganhos

REA FY25 Core Operations Net Profit A$564.4M Vs, A$460.5M>REA.AU

5 de ago. de 2025, 22:12 UTC

Ganhos

REA Group FY25 Net A$677.9M Vs. Net A$302.8M >REA.AU

5 de ago. de 2025, 21:58 UTC

Ganhos

Novo Nordisk's Earnings Come After a Dramatic Guidance Cut. What to Look for Now. -- Barrons.com

5 de ago. de 2025, 21:30 UTC

Ganhos

AMD Gives a Strong Outlook. Why the Stock Is Falling. -- Barrons.com

5 de ago. de 2025, 21:26 UTC

Ganhos

AMD CEO Expects Embedded Segment to Return to Sequential Growth in Back Half of 2025

5 de ago. de 2025, 21:23 UTC

Ganhos

AMD CEO Sees Strong Customer Interest in MI400 Series for Large-Scale Deployments

5 de ago. de 2025, 21:17 UTC

Ganhos

AMD Expects Steep Production Ramp for MI350 Series in Back Half of Year, CEO Says

5 de ago. de 2025, 21:11 UTC

Ganhos

AMD CEO Sees Durable Growth Drivers for Server CPU Business

5 de ago. de 2025, 21:07 UTC

Ganhos

AMD Set Records for Both Cloud, Enterprise CPU Sales in 2Q, CEO Says

5 de ago. de 2025, 21:01 UTC

Ganhos

Great-West Lifeco 2Q Net C$894M >GWO.T

5 de ago. de 2025, 21:01 UTC

Ganhos

Great-West Lifeco 2Q EPS C$0.96 >GWO.T

Comparação entre Pares

Variação de preço

Treace Medical Concepts Inc Previsão

Preço-alvo

By TipRanks

93.82% parte superior

Previsão para 12 meses

Média 10.35 USD  93.82%

Máximo 14.5 USD

Mínimo 8.6 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Treace Medical Concepts Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

7 ratings

2

Comprar

5

Manter

0

Vender

Pontuação Técnica

By Trading Central

7.16 / 7.65Suporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Bullish Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.